Nanjing Chia-tai Tianqing Pharmaceutical
20
2
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 20 trials
100.0%
+13.5% vs industry average
35%
7 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)
Role: lead
A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer
Role: lead
A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain
Role: lead
A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
Role: lead
Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants
Role: lead
A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients
Role: lead
A Long-term Efficacy and Safety of NTQ5082 Capsules
Role: lead
Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy
Role: lead
Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection
Role: lead
Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate Injection
Role: lead
A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers
Role: lead
Effect of Food of NTQ5082 in Healthy Subjects
Role: lead
A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors
Role: lead
A Study of Ramelteon in Chinese Patients With Chronic Insomnia
Role: lead
Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
Role: lead
A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
Role: lead
A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
Role: lead
The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation
Role: collaborator
Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases
Role: lead
Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Role: collaborator
All 20 trials loaded